Lisa Kasiewicz is a skilled professional in formulation sciences with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Sr. Advisor for Formulation Discovery at Eli Lilly and Company since October 2025, Lisa leads a subteam focused on target identification, formulation optimization, targeting ligand development, and process development scale-up. Previous roles include Associate Principal Scientist and Associate Director in Formulation at Verve Therapeutics, as well as a Researcher at AUM LifeTech. Lisa's academic background includes a PhD in Chemical Engineering from Carnegie Mellon University and a BS in Chemical Engineering from Columbia University, supplemented by research experience in bioelectronics and lipid nanoparticle development.
This person is not in any teams
This person is not in any offices